A Phase II Randomized Trial of Induction Chemotherapy Versus no Induction Chemotherapy Followed by Definitive Chemoradiotherapy in Patients With Inoperable Thoracic Esophageal Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms ICNOIC
- 03 Oct 2017 Planned End Date changed from 1 Jul 2018 to 1 Dec 2018.
- 03 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 03 May 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.